| Product Code: ETC7042945 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Communicable Diseases Treatment Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Communicable Diseases Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Communicable Diseases Treatment Market - Industry Life Cycle |
3.4 Egypt Communicable Diseases Treatment Market - Porter's Five Forces |
3.5 Egypt Communicable Diseases Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Egypt Communicable Diseases Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Egypt Communicable Diseases Treatment Market Revenues & Volume Share, By Infectious Agent, 2021 & 2031F |
3.8 Egypt Communicable Diseases Treatment Market Revenues & Volume Share, By Mode of Transmission, 2021 & 2031F |
3.9 Egypt Communicable Diseases Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.10 Egypt Communicable Diseases Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Egypt Communicable Diseases Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of communicable diseases in Egypt |
4.2.2 Growing government initiatives to improve healthcare infrastructure |
4.2.3 Rise in healthcare expenditure and investments in research and development |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas |
4.3.2 Lack of awareness about communicable diseases and their treatment |
4.3.3 High cost of advanced treatments and medications |
5 Egypt Communicable Diseases Treatment Market Trends |
6 Egypt Communicable Diseases Treatment Market, By Types |
6.1 Egypt Communicable Diseases Treatment Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Gastroenteritis, 2021- 2031F |
6.1.4 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Gonorrhoea, 2021- 2031F |
6.1.5 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Whooping Cough, 2021- 2031F |
6.1.6 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Common Cold, 2021- 2031F |
6.1.7 Egypt Communicable Diseases Treatment Market Revenues & Volume, By HIV/AIDS, 2021- 2031F |
6.1.8 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Pink Eye, 2021- 2031F |
6.1.9 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Egypt Communicable Diseases Treatment Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.2.3 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.2.4 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.2.5 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Antivirals, 2021- 2031F |
6.2.6 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Antifungal, 2021- 2031F |
6.2.7 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Antiparasitics, 2021- 2031F |
6.2.8 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Egypt Communicable Diseases Treatment Market, By Infectious Agent |
6.3.1 Overview and Analysis |
6.3.2 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Bacteria, 2021- 2031F |
6.3.3 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Viruses, 2021- 2031F |
6.3.4 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Fungi/Parasites, 2021- 2031F |
6.4 Egypt Communicable Diseases Treatment Market, By Mode of Transmission |
6.4.1 Overview and Analysis |
6.4.2 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Direct Contact, 2021- 2031F |
6.4.3 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Person-to-person Contact, 2021- 2031F |
6.4.4 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Droplet Spread, 2021- 2031F |
6.4.5 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4.6 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Indirect Contact, 2021- 2031F |
6.4.7 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Airborne Transmission, 2021- 2031F |
6.4.8 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Food and Drinking Water, 2021- 2031F |
6.4.9 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Food and Drinking Water, 2021- 2031F |
6.5 Egypt Communicable Diseases Treatment Market, By Type |
6.5.1 Overview and Analysis |
6.5.2 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Sexually Transmitted Diseases, 2021- 2031F |
6.5.3 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Helminthic Diseases, 2021- 2031F |
6.5.4 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Contact Communicable Diseases, 2021- 2031F |
6.5.5 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Oral Contamination Diseases, 2021- 2031F |
6.5.6 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Air Borne Diseases, 2021- 2031F |
6.6 Egypt Communicable Diseases Treatment Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 Egypt Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Egypt Communicable Diseases Treatment Market Import-Export Trade Statistics |
7.1 Egypt Communicable Diseases Treatment Market Export to Major Countries |
7.2 Egypt Communicable Diseases Treatment Market Imports from Major Countries |
8 Egypt Communicable Diseases Treatment Market Key Performance Indicators |
8.1 Number of patients receiving timely treatment for communicable diseases |
8.2 Percentage increase in healthcare facilities offering specialized treatments |
8.3 Rate of adoption of new technologies and treatments in communicable diseases management |
9 Egypt Communicable Diseases Treatment Market - Opportunity Assessment |
9.1 Egypt Communicable Diseases Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Egypt Communicable Diseases Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Egypt Communicable Diseases Treatment Market Opportunity Assessment, By Infectious Agent, 2021 & 2031F |
9.4 Egypt Communicable Diseases Treatment Market Opportunity Assessment, By Mode of Transmission, 2021 & 2031F |
9.5 Egypt Communicable Diseases Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.6 Egypt Communicable Diseases Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Egypt Communicable Diseases Treatment Market - Competitive Landscape |
10.1 Egypt Communicable Diseases Treatment Market Revenue Share, By Companies, 2024 |
10.2 Egypt Communicable Diseases Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here